CASTIGLIONE, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 999
EU - Europa 888
AS - Asia 155
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.051
Nazione #
US - Stati Uniti d'America 962
IT - Italia 422
GB - Regno Unito 140
IE - Irlanda 126
DE - Germania 56
CN - Cina 52
UA - Ucraina 46
VN - Vietnam 36
CA - Canada 35
FI - Finlandia 29
SE - Svezia 24
HK - Hong Kong 23
PK - Pakistan 19
SG - Singapore 13
FR - Francia 11
AT - Austria 10
RO - Romania 8
IN - India 5
AU - Australia 3
BD - Bangladesh 3
ES - Italia 3
HU - Ungheria 3
IR - Iran 3
NL - Olanda 3
CH - Svizzera 2
DK - Danimarca 2
MG - Madagascar 2
PE - Perù 2
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IL - Israele 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
Totale 2.051
Città #
Chandler 181
Dublin 126
Fairfield 84
San Mateo 82
Cambridge 61
Pisa 51
Rome 46
Wilmington 40
Seattle 38
Stevenage 38
Portsmouth 36
Ottawa 33
Southend 33
Falls Church 32
Boardman 31
Ashburn 30
Lawrence 30
Woodbridge 29
Helsinki 28
Florence 26
Houston 26
Jacksonville 24
Milan 22
Beijing 19
Dong Ket 18
Washington 15
Ann Arbor 14
Buti 14
Hong Kong 14
Livorno 14
San Diego 14
Redmond 13
Dearborn 11
Fremont 11
London 11
Dallas 10
Islamabad 9
Norwalk 9
Palermo 9
Genoa 8
West Jordan 8
Bucharest 7
Cascina 7
Central District 7
Bologna 6
Lucca 6
Zirl 6
Bari 5
Guangzhou 5
Hounslow 5
Padova 5
Redwood City 5
Acton 4
Albavilla 4
Berlin 4
Brooklyn 4
Frankfurt am Main 4
Viareggio 4
Vienna 4
Agordo 3
Amsterdam 3
Birmingham 3
Custonaci 3
Forlì 3
Hyderabad 3
Iowa City 3
Lahore 3
Los Angeles 3
Melbourne 3
Mola di Bari 3
Nanjing 3
Nuremberg 3
Oristano 3
Parma 3
Peshawar 3
Serra 3
Shenzhen 3
Varallo Pombia 3
Veresegyház 3
Barletta 2
Brescia 2
Canzo 2
Castelnuovo di Val di Cecina 2
Catania 2
Chicago 2
Chiswick 2
Concesio 2
Corigliano Calabro 2
Cosenza 2
Denver 2
Dongguan 2
Giulianova 2
Gujranwala 2
Hilden 2
Huánuco 2
Kilburn 2
Leno 2
Lugano 2
Lugo 2
Majadahonda 2
Totale 1.542
Nome #
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 119
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 117
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 94
A simple echocardiographic score to rule out cardiac amyloidosis 83
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 82
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 78
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 75
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 71
Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction 71
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 66
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 63
Treatment of cardiac transthyretin amyloidosis: an update 57
Atrial amyloidosis: mechanisms and clinical manifestations 52
Use of biomarkers to diagnose and manage cardiac amyloidosis 51
Biomarkers for the diagnosis and management of heart failure 46
Molecular autopsy of sudden cardiac death in the genomics era 46
Cardiovascular disease and COVID-19: les liaisons dangereuses 44
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 41
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 41
Current and emerging drug targets in heart failure treatment 40
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 39
Biomarkers for the diagnosis and management of heart failure: New frontiers 39
Role of Imaging in Cardiomyopathies 37
Cardiac magnetic resonance in patients with muscular dystrophies 35
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week 33
Coronary Artery Anomalies 32
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis? 31
The unbearable underreporting of comorbidities in heart failure clinical trials 30
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis 29
sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff? 29
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 28
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets 28
Safety and Efficacy of Amiodarone in a Patient With COVID-19 26
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 25
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 24
What Is Hidden Behind Inferior Negative T Waves: Multiple Cardiac Glomangiomas 22
A simple echocardiographic score to rule out cardiac amyloidosis 21
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’ 18
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis 16
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 16
Valve disease in cardiac amyloidosis: an echocardiographic score 15
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is 15
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 15
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 14
Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry 13
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 13
Stroke in ATTR cardiac amyloidosis: Does only rhythm matter? 12
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 12
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction 12
[Central apneas and cardiovascular diseases] 10
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 10
Cardiovascular toxicity from therapies for light chain amyloidosis 10
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy 10
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 7
RNA-targeting and gene editing therapies for transthyretin amyloidosis 7
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 6
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 6
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 5
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 5
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 5
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 5
Sex differences in transthyretin cardiac amyloidosis 4
Tissue Characterization in Cardiac Amyloidosis 4
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 4
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 3
Targeting precipitants to prevent heart failure hospitalization. Does season matter? 3
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond 2
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines 2
Statin therapy in COVID-19 infection 1
Totale 2.125
Categoria #
all - tutte 21.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 3 0 2 4 8 14 11 11 14 12 3 14
2020/2021344 26 28 17 27 13 26 22 24 39 24 49 49
2021/2022544 45 67 17 39 25 62 45 94 58 50 7 35
2022/2023563 33 61 23 50 58 71 23 49 103 22 51 19
2023/2024562 43 15 140 74 47 65 53 31 27 47 20 0
Totale 2.125